Payload Logo
Pharma

ImmunoGen: Q3 Earnings Snapshot

By AP News
Published

WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — ImmunoGen Inc. (IMGN) on Thursday reported third-quarter profit of $30.7 million.

On a per-share basis, the Waltham, Massachusetts-based company said it had net income of 10 cents.

The results exceeded Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of 2 cents per share.

The drug developer posted revenue of $113.4 million in the period, also exceeding Street forecasts. Eight analysts surveyed by Zacks expected $107 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMGN at https://www.zacks.com/ap/IMGN

📬 Sign up for the Daily Brief

Our free, fast and fun briefing on the global economy, delivered every weekday morning.